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Summary 
Adenylate cyclase activity in pancreatic acinar cell membranes was determined in 
rats that had undergone a treatment with pentagastrin (250 pg/kg, intraperitoneal 
three times daily) for 1 week or that had undergone small bowel resection (90%) 
and were sacrified at 2 weeks, 1 month and 6 months after intervention. Both 
treatments are potent stimulators of pancreatic acinar cell proliferation. Adenylate 
cyclase activity was similar under basal conditions and after the diterpene forskolin 
stimulation in pancreatic acinar membranes from all groups studied. The ability of 
low concentrations of the stable GTP analogue, 5’-guanylylimidodiphosphate 
(Gpp[NH]p) to inhibit forskolin- stimulated adenylate cyclase activity was decreased 
in pancreatic acinar membranes from enterectomized rats at 2 weeks and 1 month 
after the operation and returned to control values at 6 months after enterectomy. 
Stimulation of adenylate cyclase by high concentration of Gpp[NH]p or by secretin 
(lOma M) was higher in both pancreatic hyperplasia conditions as compared with 
control animals. These findings suggest hat the coupling efficiency of the G, protein 
to adenylate cyclase from pancreatic acinar membranes is enhanced without any 
alterations in the catalytic activity of the enzyme during pancreatic proliferation. In 
addition, it is possible that the highly regulated pancreatic acinar adenylate cyclase 
activity may be necessary to regulate pancreatic acinar cell proliferation. 
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Although it is generally agreed that cyclic adenosine monophosphate (CAMP) is involved in 
cellular proliferation (1,2), information on the role of CAMP-dependent signal transduction in 
regulating pancreatic acinar cell proliferation is scant. Recently, changes have been described in the 
CAMP levels during cell proliferation in a pancreatic cancer cell line cultured in vitro and in nude 
mice (3). However, evidence for CAMP-mediated stimulation of normal pancreatic acinar cell 
proliferation is uncertain. One strong stimulant of pancreatic acinar cell proliferation in the rat is an 
extensive small bowel resection (4,5). In addition, pentagastrin has also been described to lead to 
pancreatic hyperplasia (6-8). In an intent to clarify the role of CAMP-dependent processes in exocrine 
pancreas growth, we sought to study some of the cellular events that result in pancreatic acinar cell 
CAMP production in conditions of pancreatic hyperplasia in the rat. Thus, the present study 
determined adenylate cyclase activity in pancreatic acinar cell membranes from enterectomized rats 
at 2 weeks and 1 and 6 months after surgery, and at 1 week after treatment with pentagastrin. Overall 
catalytic activity of the enzyme was measured using forskolin, an agent which potently stimulates the 
catalytic subunit of adenylate cyclase (9). Experiments were also performed to measure the ability of 
inhibitory GTP-binding protein (Gi) to inhibit adenylate cyclase which is readily assessed at low 
concentrations of 5 ‘-guanylylimidodiphosphate (Gpp[NH]p), a stable GTP analogue. Under such 
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conditions Gi protein is selectively activated ue to the marked difference in affinity exhibited between 
it and stimulatory GTP-binding protein (G,) for GTP and its non-hydrolyzable analogue Gpp[NH]p. 
The effects of stimulating adenylate cyclase activity with either high Gpp[NH]p concentrations. or 
with secretin, which activate G, proteins (IO), were also studied. 
Materials and Methods 
Chemicals 
Pentagastrin was kindly donated by ICI-Farma (Spain). Secretin, forskolin, bacitracin, 
phenylmethylsulphonylfluoride (PMSF), guanosine triphosphate (GTP), 5’-guanylylimidodiphosphate 
(Gpp[NH]p); 3-isobutyl-I-methylxantine (IBMX) and bovine serum albumin were purchased from 
Sigma (St Louis, MO, USA). All other chemicals were reagent grade. 
Fifty male Wistar rats with an initial body weight of 200-250 g were used in this study. The 
animals were divided in the following groups: 
a) Small bowel resection. After a 12 hour fast, animals were randomized to receive either a 90 per 
cent proximal small bowel resection (as measured from the ligament of Treitz) with end-to-end 
anastomosis or jejunal transection and resuture (5). Operations were carried out under light ether 
anaesthesia. A continuous 6/O silk suture was used for intestinal anastomoses. Food was reintroduced 
12 h after the operation. Representatives from the resection and transection groups were killed at 2 
weeks, at 1 month and at 6 months. The survival rate of the operation was 80%. 
b) Pentagastrin. The animals received intraperitoneal injections of saline or pentagastrin (Peptavlon) 
(250 pglkg) (6), three times daily for 1 week. This dose of pentagastrin causes maximal stimulation 
of DNA synthesis in the rat (11,12). Rats were killed 8 h after the last injection. 
At the time of death, the pancreas was removed and trimmed free of fat, connective tissues, 
and lymph nodes. 
Prenaration of rat nancreatic acinar membranes 
Dispersed pancreatic acini were obtained from male Wistar rats after enzymatic degradation 
of the organ with 0.2 units of collagenase/ml in an oxygenated Krebs-Ringer medium as described 
by Amsterdam et al. (13). After thorough washing by sedimentation, acini were transferred to 0.3 
M sucrose and homogenized at 4’C by use of a Potter homogenizer following the Meldolesi et al. 
method (14). After sedimentation at 1500 g for 12 min the homogenized membranes were resuspended 
in 1.56 M sucrose. This suspension was overlaid with 0.3 M sucrose and centrifuged at 105,000 x 
g for 150 min. The plasma-membrane-enriched fraction collected from the interphase was diluted with 
distilled water and centrifuged at 13000 x g for 30 min. The supernatant was discarded and the pellet 
was resuspended in 50 mM TrisiHCl, pH 7.4, 0.01 mg/ml bacitracin, 0.2 mM CaCI, and stored at - 
7ooc. 
Adenvlate cvclase assav 
Adenylate cyclase activity was measured as previously reported (15) with minor modifications. 
Briefly, rat pancreatic acinar membranes (0.12 mg protein/ml) were incubated with 1.5 mM ATP, 
5 mM MgSO,, 1 PM GTP and ATP-regenerating system (7.5 mg/ml creatine phosphate and 1 mg/ml 
creatine kinase), 1 mM 3-isobutyl-l-methylxantine, 0.1 mM PMSF, 1 mg/ml bacitracin, 1 mM 
EDTA, and tested substances (10m9 M SS or 10m5 M FK) in 0.1 ml of 0.025 M Tris/HCl buffer (pH 
7.4). After 30 min incubation at 30°C, the reaction was stopped by heating the mixture for 3 min. 
After refrigeration, 0.2 ml of an alumina slurry (0.75 g/ml in triethanolamineiHC1 buffer, pH 7.4) 
was added and the suspension centrifuged. The supernatant was taken for assay of cyclic AMP by the 
method of Gilman (16). 
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Data analysis 
Statistical comparisons of all the data were carried out with one way analysis of variance 
(ANOVA) and the Student’s Newman-Keuls test. Means among groups were considered significantly 
different when the P value was less than 0.05. Each individual experiment was performed in 
duplicate. 
Results 
Rats with 90% small bowel resection weighed 9% less than controls at 2 weeks (247~5 versus 
270+6 g, n.s.) and 15% less at 1 month (272+7 versus 320+8 g, P<O.OOl). Pancreatic growth 
occurred with age in all experimental groups. In sham-operated rats, pancreatic wet weight increased 
from 870+8 mg at 2 weeks to 1455 + 10 mg at 1 month. In rats with proximal small bowel resection, 
pancreatic weight was 15% and 23% greater at 2 weeks (1305+41) and 1 month (2001 k66 mg, 
PC 0.01) respectively. At 6 months after 90% resection, body weights and pancreatic wet weights 
of sham-operated and resected animals did not differ significantly. The pancreatic weight in the 
pentagastrin-treated group (862f9 mg) was increased by approximately 32% as compared with the 
control group (1138flO mg). 
Mitotic figures have been observed in acinar cells after proximal small bowel resection and 
pentagastrin administration while they were absent in controls. Mitoses were never present in cells 
other than acinar cells and in enterectomized rats. they were seen only at 2 weeks of resection. 
Pancreatic acinar cell membranes exhibited similar basal adenylate cyclase activity in all 
groups studied. The diterpene forskolin, which directly stimulates the catalytic unit of adenylate 
cyclase. magnified the adenylate cyclase activity in membranes from control and treated animals by 
roughly the same amount (Fig. 1). 
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FIG. I 
Effect of 10T5 M of forskolin (hatched bars) and 10.’ M of secretin (black bars) on 
adenylate cyclase activity in pancreatic acinar membranes of pentagastrin-treated rats 
(A) or animals subjected to small bowel resection and studied 2 weeks and 1 and 6 
months after surgery (B). Open columns correspond to the control conditions. The 
asterisk indicates a significant difference (p < 0.05) between the control and resected 
groups. The results are the mean+SEM of six experiments with membranes from 
different animals. 
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Secretin stimulated the adenylate cyclase activity in pancreatic acinar cell membranes in all 
groups studied. However, the effect of secretin on adenylate cyclase activity was markedly increased 
in pancreatic acinar membranes from enterectomized rats at 2 weeks and 1 month after the operation 
and in pentagastrin-treated rats as compared with their respective controls (Fig. 1). 
Stimulation of adenylate cyclase by high concentrations of Gpp[NH]p, which fully activates 
G,, achieved a higher activation of adenylate cyclase activity in membranes from enterectomized rats 
at 2 weeks and 1 month after the operation (Fig. 2), as well as in the pentagastrin-treated rats as 
compared with the respective controls (Fig. 3). At 6 months after the operation, the stimulation of 
adenylate cyclase by high concentrations of Gpp[NH]p returned to control values (Figs. 2 and 3). 
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FIG. 2 
Dose effect curves for 5’-guanylylimidodiphosphate (Gpp[NH]p) on forskolin- 
stimulated adenylyl cyclase activity in rat pancreatic acinar cell membranes of sham- 
resected rats (0) and animals subjected to small bowel resection and studied 2 weeks 
(0) and 1 (A) and 6 (0) months after surgery. Data are expressed as a percentage 
of forskolin-stimulated activity (100%) in the absence of Gpp[NH]p. Each point is 
the mean of six experiments with membranes from different animals. The results 
express the values of a pool of the control groups, since differences among them 
were not found. For the sake of clarity, SEM are not represented but were always 
below 9% of the mean values. 
Low concentrations of Gpp[NH]p selectively activate Gi proteins, thus leading to the inhibition 
of forskolin-stimulated adenylate cyclase activity. Pancreatic acinar ceil membranes from sham- 
operated animals showed a well-defined inhibitory effect on forskolin-stimulated adenylate cyclase 
activity at low Gpp[NH]p concentrations (Fig. 2). In contrast, when pancreatic acinar cell membranes 
were used from enterectomized animals 2 weeks or 1 month after the operation, the low 
concentrations of Gpp[NH]p failed to exert an inhibitory effect on forskolin-stimulated adenylate 
cyclase activity. Inhibition was recuperated at 6 months after intestinal surgery (Fig. 2). 
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FIG. 3 
Stimulation of adenylyl cyclase activity from rat pancreatic acinar cell membranes 
with high concentrations of 5’-guanylylimidodiphosphate (Gpp[NH]p). Membranes 
from control, and pentagastrin-treated rats were used. Results are meansfSEM of 
six experiments with membranes from different animals. 
Discussion 
Although CAMP has been recognized as a second messenger for decades, the role of CAMP- 
dependent signal transduction in the regulation of compensatory pancreatic acinar cell proliferation 
remains uncertain. Therefore in the present study, adenylate cyclase activity was determined in two 
conditions of pancreatic hyperplasia in the rat: small bowel resection (5) or pentagastrin (6) 
administration. 
The inhibitory effect of low concentrations of Gpp[NH]p on forskolin-stimulated adenylate 
cyclase was markedly decreased in pancreatic acinar cell membranes from enterectomized rats 2 
weeks and 1 month after resection. This finding suggests that there is an abnormality at the Gi protein 
level in the membranes that would explain the decreased inhibition of adenylate cyclase by low 
Gpp[NH]p concentrations. 
The mechanism(s) by which Gi protein is altered 2 weeks after small bowel resection is not 
clear. A covalent modification of the a-subunit, such as a change in phosphorylation, might cause the 
alteration. On the other hand, ADP ribosylation, which is possibly a physiologically important 
mechanism for the regulation of G protein activity, might affect G, in the post-enterectomy pancreatic 
hyperplasia. Another possibility is the sequestration of G, protein. It has recently been shown that 
growth-factor induced cell division is parallelled by translocation of G, from the plasma membrane 
to the nucleus and this leads to a loss of Gi protein activity in the plasma membrane (17). The 
possibility that such a translocation took place in the exocrine pancreas after subtotal enterectomy 
simultaneous to strong cellular proliferation is a possibility that still must be confirmed. Previous 
studies by our group have found that the ability of Gpp[NH]p to inhibit forskolin-stimulated adenylate 
cyclase activity was also decreased in pancreatic acinar cell membranes from pentagastrin-treated rats 
(18). 
The functionality of G, proteins during small bowel resection and pentagastrin administration 
was tested on the basis of the capacity of high concentration of Gpp[NH]p to stimulate adenylyl 
2322 Adenylate Cyclase in Pancreatic Hyperplasia Vol. 57, No. 25, 1995 
cyclase activity in pancreatic acinar membranes from control, enterectomized- and pentagastrin-treated 
rats. 
The present study found that the exocrine pancreatic hyperplasia observed following proximal 
small bowel resection or pentagastrin administration is accompanied by an increase in the stimulatory 
effect of high concentrations of Gpp[NH]p on adenylate cyclase activity, with no changes in forskolin- 
stimulated adenylate cyclase activity, in pancreatic acinar cell membranes. These findings indicate that 
the coupling efficiency of the G, protein to adenylate cyclase is enhanced without there being any 
alterations in the catalytic unit of adenylate cyclase at 2 weeks and 1 month after enterectomy or after 
the administration of pentagastrin. The increased G, protein coupling may be due either to alterations 
in the affinity of Gpp[NH]p for the G, protein or, alternatively, to increases in the G, protein levels. 
However, since no alteration was seen in the EC,, values of Gpp[NH]p, the latter explanation seems 
more plausible. 
The present study showed increased functional activity of G, protein and decreased activity 
of Gi protein in pancreatic acinar membranes. Therefore, the G,/G, ratio is markedly increased as 
compared with the controls. It has been suggested that the cq subunit of G proteins can modulate the 
stimulatory effect of CY, on the adenylyl cyclase enzyme (19). The observed decrease of the inhibitory 
effect of low concentrations of Gpp[NH]p on FK-stimulated adenylyl cyclase in pancreatic acinar 
membranes from small bowel resection and pentagastrin-treated rats is in concordance with the 
increase of adenylyl cyclase activity at high concentrations of Gpp[NH]p. Other authors have also 
reported that the amounts of G, proteins increase during liver regeneration (20,21,22). 
It should be mentioned that it has been observed in other models that the level and function 
of G proteins is regulated and that this regulation could modulate cell responsiveness. Although the 
present results suggest hat adenylate cyclase activity in pancreatic acinar membranes is regulated after 
small bowel resection or pentagastrin administration, its role in regulation of pancreatic proliferation 
is uncertain. 
The growth-stimulating effect of CAMP may involve induction of growth-related gene 
expression. CAMP-responsive elements have been identified “upstream” of several protooncogenes 
(23), and the catalytic unit of a CAMP-dependent kinase positively regulates c-fos expression (24). 
In addition to exocrine pancreatic hyperplasia following enterectomy, the pancreatic acinar 
cells must continue to perform specific exocrine pancreas functions while the pancreas proliferates. 
It is generally agreed that CAMP is involved in the intracellular control of pancreatic bicarbonate 
secretion (25). Gelinas et al. (26) have shown that 4 weeks after a 75% resection, the bicarbonate 
output is still significantly higher in resected rats than their controls. Our data indicate that exocrine 
pancreas adenylate cyclase activity increases significantly during the first 2 and 4 weeks after small 
bowel resection and returns to control values at 6 months. These findings suggest hat the coupling 
efficiency of adenylate cyclase to the G, protein is enhanced by hyperplastic pancreas although the 
catalytic activity of the enzyme was unchanged. 
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